Related Experiment Video
Updated: Aug 10, 2026

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
[Masking of HIV antigen by specific antibodies in a model experiment]
Insights
A new competitive enzyme immunoassay (EIA) can detect human immunodeficiency virus (HIV) antigen. This test revealed that antibodies can mask HIV antigen, mimicking antigen clearance and suggesting immune response exhaustion.
Area of Science:
- Immunology
- Virology
- Diagnostic assay development
Context:
- Human immunodeficiency virus (HIV) infection diagnosis relies on detecting viral antigens and antibodies.
- Competitive enzyme immunoassays (EIA) are established diagnostic tools.
- Understanding antigen-antibody interactions is crucial for interpreting diagnostic test results.
Purpose:
- To develop a sensitive competitive EIA for detecting HIV antigen.
- To investigate the phenomenon of HIV antigen masking by antibodies in infected individuals.
- To model antigen clearance in vitro and explore its implications for HIV antigenemia.
Summary:
- A competitive EIA system capable of detecting HIV antigen at concentrations as low as 1 ng/ml was developed.
- The study demonstrated that antibodies in sera from infected individuals can bind and mask HIV antigen's determinants.
- This masking effect leads to "undetectability" of HIV antigen in the competitive EIA, serving as an in vitro model for antigen clearance when antibodies are in excess.
Impact:
- The findings provide a model for understanding antigen "clearance" in the context of excess antibodies.
- The results support the hypothesis that recurrent HIV antigenemia may result from the exhaustion of specific immune responses.
- This research contributes to a deeper understanding of HIV pathogenesis and immune evasion strategies.
Abstract:
An immuno-diagnostic test system of competitive EIA detecting HIV antigen in a concentration up to 1 ng/ml has been developed. Using this system, a phenomenon of binding of HIV antigen by antibody in sera from infected persons consisting in masking of antigenic determinants was demonstrated. The "undetectability" of HIV antigen in the system of competitive EIA caused by this phenomenon is considered to be a model of clearance of antigen at the excess of antibody in vitro. The experimental results are in agreement with the suggestion that repeated HIV antigenemia occurs as a result of exhaustion of specific immune responses.

